Truist Financial Corp Ab Cellera Biologics Inc. Transaction History

Truist Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$5.66 - $7.59 $89,999 - $120,688	-15,901 Reduced 22.87%	53,638 $346,000
Q1 2023 May 05, 2023	BUY	$7.31 - $11.18 $131,550 - $201,195	17,996 Added 34.91%	69,539 $524,000
Q4 2022 Feb 17, 2023	BUY	$9.48 - $14.52 $488,627 - $748,404	51,543 New	51,543 $522,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.